BerkiGEM2007Present6
From 2007.igem.org
(→Human Practices) |
(→Summer Work) |
||
Line 10: | Line 10: | ||
I focused my investigation on the patentability of Bacto Blood where its parts are in an open source forum given that there are existing patents on oxygen-based therapeutics. If it were possible to patent Bacto Blood, how could my team obtain patent protection for their product? | I focused my investigation on the patentability of Bacto Blood where its parts are in an open source forum given that there are existing patents on oxygen-based therapeutics. If it were possible to patent Bacto Blood, how could my team obtain patent protection for their product? | ||
- | Bacto Blood is patentable | + | Bacto Blood is patentable despite having its parts listed an open source forum. However, patentability of Bacto Blood may be complex. Two questions that read on Bacto Blood’s patentability are: |
- | 1. | + | 1. What aspects of Bacto Blood are patentable, the individual part(s), the part(s) as put together into the whole, or the applications made possible by the part(s)? |
- | 2. What starts the timeline for | + | 2. What starts the timeline for patenting Bacto Blood: when the part is put on the registry or when the applications of the part is made public? |
==Novelty and Non Obvious== | ==Novelty and Non Obvious== |
Revision as of 03:29, 25 October 2007
<< Back to UC Berkeley iGEM 2007
<< Back to Setup
Human Practices
Human Practices examines the way synthetic biology might inform human security, health, and welfare through the new objects that synthetic biology brings into the world. It also observes the ways in which economic, political, and cultural forces may shape the development of synthetic biology.
Summer Work
I focused my investigation on the patentability of Bacto Blood where its parts are in an open source forum given that there are existing patents on oxygen-based therapeutics. If it were possible to patent Bacto Blood, how could my team obtain patent protection for their product? Bacto Blood is patentable despite having its parts listed an open source forum. However, patentability of Bacto Blood may be complex. Two questions that read on Bacto Blood’s patentability are:
1. What aspects of Bacto Blood are patentable, the individual part(s), the part(s) as put together into the whole, or the applications made possible by the part(s)?
2. What starts the timeline for patenting Bacto Blood: when the part is put on the registry or when the applications of the part is made public?